BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Wu J, Shen FF, Yuan YS, Li X, Ji P, Zhu L, Sun L, Ding J, Niu Q, Zhang KZ. Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease. CNS Neurosci Ther 2020;26:518-26. [PMID: 31828965 DOI: 10.1111/cns.13282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Y, Tong Q, Yuan Y, Song X, Jiang W, Wang Y, Li W, Li Y, Zhang K. α-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model. J Neuroinflammation 2023;20:36. [PMID: 36788559 DOI: 10.1186/s12974-023-02720-1] [Reference Citation Analysis]
2 .  Corrigendum. CNS Neurosci Ther 2022. [PMID: 35751852 DOI: 10.1111/cns.13900] [Reference Citation Analysis]
3 Wang H, Xu C. A Novel Progress: Glial Cells and Inflammatory Pain. ACS Chem Neurosci 2022;13:288-95. [PMID: 35060697 DOI: 10.1021/acschemneuro.1c00607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sun L, Jiang WW, Wang Y, Yuan YS, Rong Z, Wu J, Fan Y, Lu M, Zhang KZ. Phosphorylated α-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2/NF-κB pathway. Cell Death Discov 2021;7:289. [PMID: 34642321 DOI: 10.1038/s41420-021-00676-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rong Z, Shen F, Wang Y, Sun L, Wu J, Zhang H, Yuan Y, Jiang W, Li X, Ji P, Zhang K. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis. Neurosci Lett 2021;756:135964. [PMID: 34022266 DOI: 10.1016/j.neulet.2021.135964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ma C, Zhang W, Cao M. Role of the Peripheral Nervous System in PD Pathology, Diagnosis, and Treatment. Front Neurosci 2021;15:598457. [PMID: 33994915 DOI: 10.3389/fnins.2021.598457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fan S, Yin Q, Li D, Ma J, Li L, Chai S, Guo H, Yang Z. Anti-neuroinflammatory effects of Eucommia ulmoides Oliv. In a Parkinson's mouse model through the regulation of p38/JNK-Fosl2 gene expression. J Ethnopharmacol 2020;260:113016. [PMID: 32464317 DOI: 10.1016/j.jep.2020.113016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Zhang X, Zhang Y, Li R, Zhu L, Fu B, Yan T. Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis. Aging (Albany NY) 2020;12:9405-26. [PMID: 32432571 DOI: 10.18632/aging.103215] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 12.3] [Reference Citation Analysis]
9 Zhang H, Wu J, Shen FF, Yuan YS, Li X, Ji P, Zhu L, Sun L, Ding J, Niu Q, Zhang KZ. Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease. CNS Neurosci Ther 2020;26:518-26. [PMID: 31828965 DOI: 10.1111/cns.13282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]